Article Text

Download PDFPDF
The winner takes it all
  1. K Walsh
  1. Correspondence to:
 K Walsh
 BMA House, Tavistock Square, London, WC1H 9JR;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We all make mistakes from time to time. I have made my fair share, but none of my mistakes have ever won a prize.

In 2002 Lundbeck breached the UK industry code of practice in the way it advertised escitalopram (Cipralex). Escitalopram is the son of citalopram (Cipramil). The company claimed that its new drug, escitalopram was more effective than citalopram, even though the two drugs have exactly the same active ingredient.1

The company was found to have breached the industry code, mainly by stating that “Cipralex is significantly more effective than Cipramil in treating depression”. The company also attributed side effects to citalopram in its literature on escitalopram that were not mentioned …

View Full Text